Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.1620
-0.1941-54.51%
Post-market: 0.27000.1080+66.67%19:59 EDT
Volume:3.85M
Turnover:1.03M
Market Cap:2.64M
PE:-0.06
High:0.3490
Open:0.3490
Low:0.1620
Close:0.3561
52wk High:5.20
52wk Low:0.1620
Shares:16.29M
Float Shares:12.55M
Volume Ratio:2.75
T/O Rate:30.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8935
EPS(LYR):-4.8401
ROE:-136.16%
ROA:-73.78%
PB:0.17
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Mangoceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
3
Office Location:
15110 N. Dallas Parkway,Suite 600,Dallas,Texas,United States
Zip Code:
75248
Fax:
- -
Introduction:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Directors

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Alex P. Hamilton
Independent Director
Kenny Myers
Independent Director
Lorraine D Alessio
Independent Director

Shareholders

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Eugene M. Johnston
Chief Financial Officer